Ipca Laboratories’ Tarapur API plant receives US FDA Form 483 with three observations

The inspection was carried out from December 1, 2025, to December 5, 2025. According to the company, the observations were shared at the conclusion of the inspection. Shares of IPCA Laboratories Ltd ended at ₹1,440.15, down by ₹17.00, or 1.17%, on the BSE.

Leave a Reply

Your email address will not be published. Required fields are marked *